DUBLIN--(BUSINESS WIRE)--The "Diabetes Care Devices Market by Type (SMBG, CGMS, Lancets, Insulin Pumps, Insulin Pens, Insulin Syringes, Mobile Apps), Patient Care Settings (Hospitals & Specialty Clinics, Self & Home Care), and Country (Brazil, Russia, India, China) - Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The diabetes care devices (BRIC) market size is projected to reach USD 4.3 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 16.2% during the forecast period.
The growth in this market is primarily attributed to the sharp increase in diabetes, increasing awareness of diabetes management due to the rising number of diabetes awareness campaigns and screening camps, favorable national health strategies, and government-led endorsement of medical devices.
By type, under the insulin delivery devices segment, insulin pens to hold the largest share during the forecast period
Within the type category, the diabetes care devices (BRIC) market has been segmented into blood glucose monitoring systems, insulin delivery devices, and diabetes management mobile applications. Within the insulin delivery devices segment, insulin pens held the largest share in the market. The increasing affordability of insulin pens, convenience, ease-of-use, and technological advancements in these devices that promote integrated diabetes management support the growth of this segment.
By end-user, the self/ home healthcare segment is expected to grow at a higher rate during the forecast period (2020-2025)
Based on end-user, the diabetes care devices (BRIC) market has been segmented into hospital & specialty clinics and self/home healthcare. The self/home healthcare segment is expected to grow at a higher CAGR due to the increasing awareness of self-management of diabetes, increasing portability of diabetes care devices, and technological innovations that provide real-time insights for patients and healthcare providers for decision-making regarding diabetes control and treatment planning.
India is projected to grow at the highest CAGR
China is expected to account for the largest share of the diabetes care devices (BRIC) market in 2019. The large share of this region can primarily be attributed to the sharp increase in the diabetic population in the past decade and endorsements of medical devices by the government. On the other hand, India is expected to witness the highest CAGR during the forecast period due to the increasing government investment in the medical devices industry, high prevalence of type 1 and gestational diabetes cases, and increasing diabetes awareness creation through campaigns and screening camps.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Industry Insights
6 Diabetes Care Devices Market, by Type
7 Diabetes Care Devices Market, by Patient Care Settings
7.2 Self/Home Healthcare
7.3 Hospitals & Diabetes Specialty Clinics
8 Diabetes Care Devices Market in BRIC Countries
8.2 China: Diabetes Care Devices Market
8.2.2 Market Drivers
126.96.36.199 Sharp Increase in Diabetes in the Past Decade
188.8.131.52 Favorable National Health Strategies
184.108.40.206 Government-Led Endorsement of the Medical Device Industry
8.2.3 Market Restraints
220.127.116.11 Traditional Chinese Medicine As an Alternative
18.104.22.168 High Cost of Advanced Diabetes Management Devices
8.2.4 Market Opportunities
22.214.171.124 Significant Advancements and Leveraging of Artificial Intelligence and Big Data
8.2.5 Market Challenges
126.96.36.199 Lack of Adherence of Patients to Recommended Diabetes Treatment Guidelines
8.3 India: Diabetes Care Devices Market
8.3.2 Market Drivers
188.8.131.52 High Prevalence of Diabetes
184.108.40.206 Government's Make in India Campaign to Encourage Local Manufacturing of Medical Devices
220.127.116.11 Diabetes Awareness Campaigns and Screening Camps
8.3.3 Market Restraints
18.104.22.168 Lack of Accessibility to Healthcare
22.214.171.124 Inadequate Health Insurance Coverage
8.3.4 Market Opportunities
126.96.36.199 Rising Adoption of Mhealth
8.3.5 Market Challenges
188.8.131.52 Shortage of Healthcare Professionals in Diabetes Management
8.4 Brazil: Diabetes Care Devices Market
8.4.2 Market Drivers
184.108.40.206 High Prevalence of Diabetes
220.127.116.11 Favorable Government Policies
8.4.3 Market Restraints
18.104.22.168 Lack of Awareness of Diabetes Care
22.214.171.124 High Prices of Advanced Diabetes Care Devices
8.4.4 Market Opportunities
126.96.36.199 Increasing Penetration of Smartphones and Rising Focus on Digital Health to Drive the Growth of Diabetes Management Platforms and Diabetes Management Mobile Applications
8.4.5 Market Challenges
188.8.131.52 Strict Regulatory Guidelines and Regulatory Process for Medical Devices
8.5 Russia: Diabetes Care Devices Market
8.5.2 Market Drivers
184.108.40.206 Rising Elderly Population
220.127.116.11 Increasing Rate of Obesity
8.5.3 Market Restraints
18.104.22.168 Large Number of Undiagnosed Diabetics
8.5.4 Market Opportunities
22.214.171.124 Government Spending on Healthcare
126.96.36.199 Rising Investment of Pharma Market Players to Establish Local Manufacturing Plants
8.5.5 Market Challenges
188.8.131.52 Low Adoption of Glucose Monitoring Systems
9 Competitive Landscape
9.2 Product Benchmarking
9.3 Geographic Reach of the Top Market Players (2019)
9.4 R&D Expenditure: Key Players in the Diabetes Care Devices (Bric) Market
9.5 Market Share Analysis
10 Company Profiles
10.1 F. Hoffman-La Roche Ltd.
10.3 Ascensia Diabetes Care Holdings Ag
10.4 Dexcom, Inc.
10.5 Medtronic Plc
10.6 B. Braun Melsungen Ag
10.7 Becton, Dickinson and Company
10.8 Acon Laboratories, Inc.
10.9 Arkray, Inc.
10.11 Novo Nordisk A/S
10.12 Terumo Corporation
10.14 Sinocare, Inc.
10.15 Agamatrix Holdings Llc
10.17 Sd Biosensor, Inc.
10.18 Microgene Diagnostic Systems Pvt. Ltd.
10.19 Dr. Morepen
10.20 Bionime Corporation
10.21 Rossmax International Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/rqbdp4